Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2019 Mar 15;13(1 Pt 1):83–93. doi: 10.1016/j.jcmg.2019.02.005

Table 3 -.

Hazard Ratios for all-cause and cause-specific mortality by CAC score group

A. CAC 0 as reference group
Model 1 - Unadjusted HRs
Agatston score Cause of Mortality, HR (95% CI)
CVD CHD Cancer All-cause
0 REF REF REF REF
1–399 3.49 (2.85 – 4.27) 4.14 (3.05 – 5.63) 1.96 (1.70 – 2.26) 2.50 (2.28 – 2.75)
400–999 10.85 (8.63 – 13.64) 14.86 (10.64 – 20.74) 3.52 (2.88 – 4.30) 6.07 (5.39 – 6.83)
≥ 1000 24.23 (19.49 – 30.12) 36.26 (26.44 – 49.73) 5.87 (4.80 – 7.18) 11.64 (10.38 – 13.05)
Model 2 - Fully adjusted HRs
Agatston score Cause of Mortality, HR (95% CI)
CVD CHD Cancer All-cause
0 REF REF REF REF
1–399 1.77 (1.43 – 2.18) 1.99 (1.45 – 2.74) 1.09 (0.94 – 1.27) 1.37 (1.24 – 1.52)
400–999 3.09 (2.41 – 3.97) 3.90 (2.72 – 5.59) 1.19 (0.95 – 1.48) 1.98 (1.73 – 2.25)
≥ 1000 5.04 (3.92 – 6.48) 6.79 (4.74 – 9.73) 1.55 (1.23 – 1.95) 2.89 (2.53 – 3.31)
B. CAC 400–999 as reference group
Model 1 - Unadjusted HRs
Agatston score Cause of Mortality, HR (95% CI)
CVD CHD Cancer All-cause
400–999 REF REF REF REF
≥ 1000 2.23 (1.84 – 2.70) 2.43 (1.90 – 3.11) 1.65 (1.31 – 2.09) 1.91 (1.69 – 2.15)
≥ 1000 1.71 (1.41 – 2.08) 1.84 (1.43 – 2.36) 1.36 (1.07 – 1.73) 1.51 (1.33 – 1.70)
Model 2 - Fully adjusted HRs
Agatston score Cause of Mortality, HR (95% CI)
CVD CHD Cancer All-cause
400–999 REF REF REF REF
≥ 1000 1.71 (1.41 – 2.08) 1.84 (1.43 – 2.36) 1.36 (1.07 – 1.73) 1.51 (1.33 – 1.70)
*

Adjusted on age, sex, hypertension, dyslipidemia, smoking, diabetes, and family history of CHD